Physician profile
Stephanie E Champion
NPI 1518130459
$2,521.85
in general payments reported to CMS, 2019-2025
33 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $347 · 2021: $384 · 2022: $410 · 2023: $358 · 2024: $353 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $391.41 | 2020-2025 | Liletta |
| Avion Pharmaceuticals | $236.08 | 2019-2023 | Balcoltra |
| Exeltis, USA INC. | $188.89 | 2019-2024 | Tyblume, Slynd |
| Mayne Pharma Commercial LLC | $173.30 | 2021-2025 | |
| Astellas Pharma US INC | $138.22 | 2024-2025 | Veozah |
| Biogen, INC. | $134.77 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $116.87 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $112.81 | 2019-2021 | |
| Organon LLC | $103.40 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $102.15 | 2024-2025 | Myfembree, Gemtesa |
| Allergan, INC. | $94.41 | 2019-2020 | |
| Lupin INC. | $79.00 | 2019-2020 | |
| Millicent US INC | $67.58 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Aspira Women'S Health INC | $66.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.89 | 2019-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $47.21 | 2023 | Twirla |
| Therapeuticsmd, INC. | $41.34 | 2019 | |
| Evofem Biosciences, INC. | $35.91 | 2021 | |
| Hologic Sales and Service, LLC | $34.80 | 2023 | Aptima |
| Mylan Pharmaceuticals INC. | $34.17 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $30.15 | 2019 | |
| Coopersurgical, INC. | $29.45 | 2021-2022 | |
| Boston Scientific Corporation | $24.44 | 2024 | |
| Acessa Health INC. | $24.38 | 2020 | |
| Optumhealth Care Solutions, LLC | $23.35 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Duchesnay USA Incorporated | $21.86 | 2019 | |
| Intuitive Surgical, INC. | $20.58 | 2019 | |
| Ethicon US, LLC | $20.46 | 2024 | Enseal |
| Biom'Up France Sas | $19.75 | 2020 | |
| Smith+Nephew, INC. | $17.28 | 2025 | Pico 7 |
| Kesin Pharma Corporation | $15.74 | 2023 | Likmez |
| Scynexis, INC. | $13.99 | 2022 | |
| Mission Pharmacal Company | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Champion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.